| Alicia Cox, DO | |
|
155 Memorial Dr, Pinehurst, NC 28374-8710 | |
| (302) 733-1042 | |
| Not Available |
| Full Name | Alicia Cox |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 155 Memorial Dr, Pinehurst, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124522594 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2021-02460 (North Carolina) | Primary |
| Entity Name | Sandhills Emergency Physicians Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003853409 PECOS PAC ID: 8729062609 Enrollment ID: O20040617000371 |
News Archive
African-Americans with work-related back injuries have less money spent on their medical care and receive less compensation for their injuries than Caucasians, according to a Saint Louis University study in the December issue of Pain.
A new guideline developed by the American Academy of Neurology found that the best treatment for vertigo is the easiest and quickest one. The guideline on benign paroxysmal positional vertigo (BPPV), an inner ear disorder that is a common cause of dizziness, is published in the May 27, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
Antibiotic resistance is increasing throughout the world because of excessive use, Agence France-Press reports. The news service writes, "Experts at the 2nd annual European antibiotics awareness day held by the Stockholm-based European Centre for Diseases Prevention and Control (ECDC) said new, hyper-resistant bacteria were emerging, threatening the pillars of global health."
InSite Vision Incorporated today announced that patient enrollment has been completed in the DOUBle Phase 3 clinical trial of AzaSite Plus (ISV-502) and DexaSite (ISV-305) for the treatment of blepharitis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alicia Cox, DO 355 W Maine Ave, Southern Pines, NC 28387-4703 Ph: (302) 331-6647 | Alicia Cox, DO 155 Memorial Dr, Pinehurst, NC 28374-8710 Ph: (302) 733-1042 |
News Archive
African-Americans with work-related back injuries have less money spent on their medical care and receive less compensation for their injuries than Caucasians, according to a Saint Louis University study in the December issue of Pain.
A new guideline developed by the American Academy of Neurology found that the best treatment for vertigo is the easiest and quickest one. The guideline on benign paroxysmal positional vertigo (BPPV), an inner ear disorder that is a common cause of dizziness, is published in the May 27, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
Antibiotic resistance is increasing throughout the world because of excessive use, Agence France-Press reports. The news service writes, "Experts at the 2nd annual European antibiotics awareness day held by the Stockholm-based European Centre for Diseases Prevention and Control (ECDC) said new, hyper-resistant bacteria were emerging, threatening the pillars of global health."
InSite Vision Incorporated today announced that patient enrollment has been completed in the DOUBle Phase 3 clinical trial of AzaSite Plus (ISV-502) and DexaSite (ISV-305) for the treatment of blepharitis.
› Verified 7 days ago
Don Robert Bahner Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-1000 | |
Darrell Simpkins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-1000 | |
Matthew Reinhardt, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-1000 | |
Ronald Milewski, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-692-8224 | |
Carlin Corsino, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-1000 | |
Mary Peterson-suri, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-1000 |